Description
The 23-valent vaccine accounts for at least 90% of pneumococcal blood isolates and at least 85% of all pneumococcal isolates from sites which are generally sterile as determined by ongoing surveillance of United States data.
PNEUMOCOCCAL VACCINE, POLYVALENT (PNEUMOVAX 23) is manufactured according to methods developed by the MERCK RESEARCH LABORATORIES. Each 0.5 mL dose of vaccine contains 25 mcg of each polysaccharide type dissolved in isotonic saline solution containing 0.25% phenol as a preservative.